| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0761-8425(08)71512-2 |
| P698 | PubMed publication ID | 18449076 |
| P2093 | author name string | C Camus | |
| B Philippe | |||
| J-P Gangneux | |||
| P2860 | cites work | Detection of Aspergillus galactomannan antigenemia to determine biological and clinical implications of beta-lactam treatments | Q24533425 |
| Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference | Q28207287 | ||
| Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis | Q28217179 | ||
| Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia | Q28284944 | ||
| Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis | Q28377349 | ||
| Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis | Q30659487 | ||
| Invasive aspergillosis in transplant recipients | Q33589376 | ||
| Aspergillus infections in transplant recipients | Q33719294 | ||
| Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis | Q33962952 | ||
| Aspergillus valve endocarditis in patients without prior cardiac surgery. | Q34002103 | ||
| Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy | Q34033598 | ||
| Bifidobacterial lipoglycan as a new cause for false-positive platelia Aspergillus enzyme-linked immunosorbent assay reactivity | Q34041860 | ||
| Fungal endocarditis: evidence in the world literature, 1965-1995. | Q34105375 | ||
| Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature | Q34131043 | ||
| Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review | Q34230722 | ||
| Fungal infections in patients undergoing blood and marrow transplantation | Q34294869 | ||
| Approaches to fungal diagnosis in transplantation | Q34294880 | ||
| Infectious complications of solid organ transplantations | Q34305102 | ||
| Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis | Q71520221 | ||
| Aspergillus fumigatus infection of a biloma | Q71910983 | ||
| Invasive pulmonary aspergillosis associated with low dose methotrexate therapy for rheumatoid arthritis: a case report of treatment with itraconazole | Q72062828 | ||
| Fatal invasive aspergillosis during cyclosporine and steroids treatment for Crohn's disease | Q72642727 | ||
| Aspergilloma complicating cystic fibrosis | Q72881258 | ||
| Infection in the transplanted and native lung after single lung transplantation | Q72911375 | ||
| Native lung pneumonectomy for invasive pulmonary aspergillosis following lung transplantation: a case report | Q73061847 | ||
| A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group | Q73165218 | ||
| A renal transplant recipient with acute paraparesis due to an Aspergillus epidural abscess | Q73832415 | ||
| Pulmonary aspergillosis and central nervous system hemorrhage as complications of autoimmune hemolytic anemia treated with corticosteroids | Q73853549 | ||
| Aspergillus airway colonization and invasive disease after lung transplantation | Q73875975 | ||
| Causes of death in patients with systemic lupus erythematosus in São Paulo, Brazil: a study of 113 autopsies | Q74100418 | ||
| Diagnosis and treatment of Aspergillus flavus sternal wound infections after cardiac surgery | Q74782427 | ||
| Pulmonary aspergillosis and invasive disease in AIDS: review of 342 cases | Q74800410 | ||
| Isolated urinary aspergillosis in a renal transplant recipient | Q77373223 | ||
| Pulmonary aspergillosis in cystic fibrosis lung transplant recipients | Q77585144 | ||
| Urinary tract aspergillosis in a renal transplant recipient | Q77595551 | ||
| Images in clinical medicine. Aspergilloma as a complication of pacemaker implantation | Q77607675 | ||
| Complications in the native lung after single lung transplantation | Q78155328 | ||
| Adult respiratory distress syndrome in systemic lupus erythematosus: causes and prognostic factors: a single center, retrospective study | Q78248090 | ||
| Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey | Q80052810 | ||
| Invasive aspergillosis in critically ill patients without malignancy | Q80269940 | ||
| Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance | Q80312940 | ||
| Posaconazole | Q80403726 | ||
| [Complex respiratory aspergillosis: diagnostic and therapeuthic difficulties] | Q81522995 | ||
| Aspergillosis in lung transplantation: incidence, risk factors, and prophylactic strategies | Q34330077 | ||
| Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. | Q34455633 | ||
| Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation | Q34498204 | ||
| Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease | Q34574325 | ||
| Fungal endocarditis, 1995-2000. | Q34735765 | ||
| Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates | Q35011464 | ||
| Aspergillosis. Pathogenesis, clinical manifestations, and therapy | Q35038459 | ||
| Fungal infections in the recipients of solid organ transplantation | Q35129031 | ||
| Invasive pulmonary aspergillosis soon after therapy with infliximab, a tumor necrosis factor-alpha-neutralizing antibody: a possible healthcare-associated case? | Q35187336 | ||
| Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients | Q35552743 | ||
| Invasive pulmonary fungal infections in solid organ transplant recipients: a four-year review | Q35581463 | ||
| Glucocorticoids and invasive fungal infections | Q35599856 | ||
| New clinical presentations of invasive aspergillosis in non-conventional hosts. | Q35641411 | ||
| Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis | Q35789251 | ||
| Prophylactic strategies before solid-organ transplantation | Q35829558 | ||
| Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients | Q36087577 | ||
| Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts | Q36098515 | ||
| Laboratory diagnosis of invasive aspergillosis. | Q36267587 | ||
| Specific antibody detection in invasive aspergillosis by analytical isoelectrofocusing and immunoblotting methods | Q36520973 | ||
| Three cases of pulmonary aspergilloma in adult patients with cystic fibrosis | Q36559897 | ||
| Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes | Q39652863 | ||
| Fulminant invasive pulmonary aspergillosis in immunocompetent patients--a two-case report | Q40543559 | ||
| Invasive aspergillosis in the setting of cardiac transplantation. | Q40550342 | ||
| Invasive Aspergillosis in Italian AIDS patients | Q40569326 | ||
| Pelvic aspergillosis with tubo-ovarian abscess in a renal transplant recipient | Q40596958 | ||
| A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group | Q40612309 | ||
| Improved outcome of pulmonary aspergillosis in heart transplant recipients with early diagnosis and itraconazole treatment | Q40616573 | ||
| Fatal invasive aspergillosis in an adolescent with cystic fibrosis | Q40820612 | ||
| Peracute disseminated fatal Aspergillus fumigatus sepsis as a complication of corticoid-treated systemic lupus erythematosus | Q41042897 | ||
| Infectious ocular complications in orthotopic liver transplant patients | Q41508709 | ||
| NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis | Q42599568 | ||
| Central nervous system Aspergillus fumigatus infection after near drowning | Q43010833 | ||
| Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients | Q43721640 | ||
| Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management | Q43722691 | ||
| Invasive Aspergillosis in Renal Transplant Recipients: Correlation with Corticosteroid Therapy | Q43727589 | ||
| Why prior fluconazole use is associated with an increased risk of invasive mold infections in immunosuppressed hosts: an alternative hypothesis | Q43952852 | ||
| Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients | Q43961537 | ||
| Disseminated aspergillosis in intensive care unit patients: an autopsy study | Q44392075 | ||
| Voriconazole inhibition of tacrolimus metabolism. | Q44396669 | ||
| Outbreak of invasive aspergillosis among renal transplant recipients | Q44405400 | ||
| Invasive aspergillosis in liver transplant recipients: outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B. | Q44493935 | ||
| Incidence and significance of Aspergillus cultures following liver and kidney transplantation | Q44527992 | ||
| Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants | Q44606439 | ||
| Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients | Q44620997 | ||
| False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. | Q44688423 | ||
| Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients | Q44691631 | ||
| Risk factors for invasive aspergillosis in liver transplant recipients | Q44752127 | ||
| Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis | Q44800864 | ||
| Aspergillosis presenting as Koebner's phenomenon in a healed scald | Q44839630 | ||
| Aspergillosis of the testis in a renal transplant recipient | Q46878613 | ||
| Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism | Q46902191 | ||
| Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study | Q46943408 | ||
| Cerebral aspergillosis: long term efficacy and safety of liposomal amphotericin B in kidney transplant | Q48364331 | ||
| Isolated cerebral aspergillosis without a portal of entry--complete recovery after liposomal amphotericin B and surgical treatment | Q48381205 | ||
| Aspergillosis in 25 renal transplant patients. Epidemiology, clinical presentation, diagnosis, and management | Q48721208 | ||
| Invasive pulmonary aspergillosis after near-drowning | Q50123242 | ||
| Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis. | Q50495768 | ||
| The isolation of Aspergillus fumigatus from respiratory tract specimens in heart transplant recipients is highly predictive of invasive aspergillosis. | Q51190760 | ||
| Significance of Aspergillus fumigatus isolation from respiratory specimens of nongranulocytopenic patients. | Q51660555 | ||
| An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis. | Q53349495 | ||
| Infectious complications of lung transplantation. Impact of cystic fibrosis. | Q54205174 | ||
| Transient aspergillus antigenaemia: think of milk | Q56838494 | ||
| Comparison of Serum Galactomannan Antigen Detection and Competitive Polymerase Chain Reaction for Diagnosing Invasive Aspergillosis | Q56838521 | ||
| Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area | Q56941303 | ||
| Galactomannan in Bronchoalveolar Lavage Fluid | Q57559940 | ||
| Trends in Risk Profiles for and Mortality Associated with Invasive Aspergillosis among Liver Transplant Recipients | Q57569380 | ||
| Pneumonia After Heart Transplantation: A Multiinstitutional Study | Q57569463 | ||
| Invasive Pulmonary Aspergillosis Associated with Infliximab Therapy | Q57780453 | ||
| Surgical wound infection by Aspergillus fumigatus in liver transplant recipients | Q58405729 | ||
| Post-traumatic intracranial epiduralAspergillus fumigatusabscess | Q61758378 | ||
| Pre-emptive therapy with azoles in lung transplant patients | Q63370910 | ||
| INVASIVE ASPERGILLOSIS IN LIVER TRANSPLANT RECIPIENTS IN THE 1990s | Q63859753 | ||
| Aspergillus Infection of the Burn Wound | Q66944772 | ||
| Guidelines for the use of systemic glucocorticosteroids in the management of selected infections. Working Group on Steroid Use, Antimicrobial Agents Committee, Infectious Diseases Society of America | Q67718812 | ||
| Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids | Q68926740 | ||
| Risk of infectious complications in patients taking glucocorticosteroids | Q69561570 | ||
| Aspergillus infection in single and double lung transplant recipients | Q71062292 | ||
| P433 | issue | 2 | |
| P921 | main subject | epidemiology | Q133805 |
| invasive aspergillosis | Q3625278 | ||
| P304 | page(s) | 139-153 | |
| P577 | publication date | 2008-02-01 | |
| P1433 | published in | Revue des Maladies Respiratoires | Q15708750 |
| P1476 | title | [Epidemiology of and risk factors for invasive aspergillosis in nonneutropenic patients] | |
| P478 | volume | 25 |
| Q30276951 | A computational model of invasive aspergillosis in the lung and the role of iron |
| Q33628773 | Distinct roles for Dectin-1 and TLR4 in the pathogenesis of Aspergillus fumigatus keratitis |
| Q34031555 | Miliary nodules: An unusual presentation of allergic bronchopulmonary aspergillosis |
| Q41461790 | Some fungi in the air. Interview by Sophia Häfner |
Search more.